Annuncio • Jun 04
Marechale Capital Plc (AIM:MAC) entered into share purchase agreements with Blubird Labs Inc. for £0.42 million. Marechale Capital Plc (AIM:MAC) entered into share purchase agreements with Blubird Labs Inc. for £0.42 million on June 3, 2026. The consideration consists of 23.72 million common equity of Marechale Capital Plc having a value of £0.52 million to be issued for common equity of Blubird Labs Inc. As part of consideration, £0.52 million is paid towards common equity of Blubird Labs Inc. In a separate but related transactions, Marechale Capital Plc also acquired Stanford Capital Partners and NJC Capital.
The transaction is subject to approval of offer by acquirer shareholders. Reported Earnings • Jan 21
First half 2026 earnings released: UK£0.002 loss per share (vs UK£0.002 loss in 1H 2025) First half 2026 results: UK£0.002 loss per share (in line with 1H 2025). Revenue: UK£111.9k (down 25% from 1H 2025). Net loss: UK£176.5k (loss narrowed 1.0% from 1H 2025). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Annuncio • Oct 15
Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.2025 million. Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.2025 million.
Security Name: Ordinary shares
Security Type: Common Stock
Securities Offered: 8,833,336
Price\Range: £0.015
Security Name: Ordinary shares
Security Type: Common Stock
Securities Offered: 4,666,670
Price\Range: £0.015 New Risk • Oct 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (UK£409k revenue, or US$546k). Market cap is less than US$10m (UK£1.85m market cap, or US$2.47m). Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change). Annuncio • Oct 14
Marechale Capital Plc has filed a Follow-on Equity Offering in the amount of £0.2025 million. Marechale Capital Plc has filed a Follow-on Equity Offering in the amount of £0.2025 million.
Security Name: Ordinary shares
Security Type: Common Stock
Securities Offered: 8,833,336
Price\Range: £0.015
Security Name: Ordinary shares
Security Type: Common Stock
Securities Offered: 4,666,670
Price\Range: £0.015 Annuncio • Sep 16
Marechale Capital Plc, Annual General Meeting, Oct 14, 2025 Marechale Capital Plc, Annual General Meeting, Oct 14, 2025. Location: 46 new broad st, london ec2m 1jh United Kingdom Reported Earnings • Aug 25
Full year 2025 earnings released: UK£0.003 loss per share (vs UK£0.002 loss in FY 2024) Full year 2025 results: UK£0.003 loss per share (further deteriorated from UK£0.002 loss in FY 2024). Revenue: UK£409.4k (down 39% from FY 2024). Net loss: UK£337.3k (loss widened 84% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance. New Risk • Jul 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (UK£496k revenue, or US$663k). Market cap is less than US$10m (UK£2.48m market cap, or US$3.32m). Minor Risks Latest financial reports are more than 6 months old (reported October 2024 fiscal period end). Share price has been volatile over the past 3 months (8.0% average weekly change). New Risk • Jul 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended October 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (UK£496k revenue, or US$676k). Market cap is less than US$10m (UK£2.27m market cap, or US$3.09m). Minor Risk Latest financial reports are more than 6 months old (reported October 2024 fiscal period end). New Risk • Jan 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 33% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (33% average weekly change). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (UK£496k revenue, or US$617k). Market cap is less than US$10m (UK£4.02m market cap, or US$4.99m). New Risk • Dec 20
New major risk - Revenue and earnings growth Earnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (UK£496k revenue, or US$624k). Market cap is less than US$10m (UK£1.53m market cap, or US$1.93m). Annuncio • Sep 20
Marechale Capital Plc, Annual General Meeting, Oct 15, 2024 Marechale Capital Plc, Annual General Meeting, Oct 15, 2024. Location: 46 new broad st, ec2m 1jh, london United Kingdom Reported Earnings • Aug 21
Full year 2024 earnings released: UK£0.002 loss per share (vs UK£0.004 loss in FY 2023) Full year 2024 results: UK£0.002 loss per share (improved from UK£0.004 loss in FY 2023). Revenue: UK£668.4k (up 78% from FY 2023). Net loss: UK£183.0k (loss narrowed 57% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Annuncio • Aug 06
Marechale Capital plc Appoints Chris Kenning as Non-Executive Director Marechale Capital plc announced the appointment of Mr. Chris Kenning as Non-executive Director of the Company with immediate effect. As announced on June 28, 2023, Mr. Chris Kenning made a strategic investment in the Company, acquiring approximately 9.89 per cent. of the Company’s issued share capital at the time. As a part of the subscription, Mr. Kenning was provided with the right to join the board of the Company as a Non-executive Director, subject to the completion of regulatory and due diligence processes. Mr. Kenning is a longstanding experienced corporate finance professional, currently serving as the founder and Chief Executive Officer at Stubben Edge Group Ltd. since 2018, following a Management Buyout of two IOMA companies, IOMA Broking (UK) Ltd. and IOMA Group (UK) Ltd, where he had been a director since 2010 and 2014 respectively. Previously he was a director at IOMA Group including the roles of Managing Director from 2014 to 2018 and Group Finance Director from 2011 to 2014. Prior to this he was corporate finance manager at Strand Partners (now Hannam & Partners) from 2010 to 2011. Mr. Kenning graduated from the University of Edinburgh in 2006 with an MA Economic History. He joined Grant Thornton from 2007 to 2010, where he qualified as a chartered accountant and was admitted to the Institute of Chartered Accountants in England & Wales (ICAEW). New Risk • Jun 23
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended October 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue is less than US$1m (UK£528k revenue, or US$667k). Market cap is less than US$10m (UK£1.51m market cap, or US$1.91m). Minor Risks Latest financial reports are more than 6 months old (reported October 2023 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). New Risk • Feb 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (UK£528k revenue, or US$669k). Market cap is less than US$10m (UK£1.74m market cap, or US$2.21m). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding). Reported Earnings • Dec 07
First half 2024 earnings released: UK£0.001 loss per share (vs UK£0.002 loss in 1H 2023) First half 2024 results: UK£0.001 loss per share (improved from UK£0.002 loss in 1H 2023). Revenue: UK£320.2k (up 91% from 1H 2023). Net loss: UK£155.8k (loss narrowed 13% from 1H 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Annuncio • Nov 24
Marechale Capital Plc Announces Stepped Down of Lord Howard Flight as Non-Executive Director Marechale Capital plc announced that Lord Howard Flight, a non-executive director of the company, has stepped down from his role with the company with immediate effect due to reasons of ill health. Lord Flight has been an invaluable member of the board since his appointment in September 2006, contributing his expertise, insights and commitment to the company. Annuncio • Sep 21
Marechale Capital Plc, Annual General Meeting, Oct 13, 2023 Marechale Capital Plc, Annual General Meeting, Oct 13, 2023, at 11:00 Coordinated Universal Time. Location: 46 New Broad St., London United Kingdom Agenda: To consider the financial statements for the year ended 30 April 2023 and the Reports of the Directors and Auditors thereon; to consider and re-appoint Messrs UHY Hacker young LLP as auditors and authorize the directors to determine their remuneration; to consider re-election of Directors of the Company; to grant the directors authority to allot shares in the Company or grant rights to subscribe for, or to convert any security, into shares in the Company; and to consider and dis-apply statutory pre-emption rights in connection with the allotment of equity securities for cash. Reported Earnings • Aug 23
Full year 2023 earnings released: UK£0.004 loss per share (vs UK£0.029 profit in FY 2022) Full year 2023 results: UK£0.004 loss per share (down from UK£0.029 profit in FY 2022). Revenue: UK£374.8k (down 40% from FY 2022). Net loss: UK£425.5k (down 117% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. New Risk • Jul 28
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (47% accrual ratio). Revenue is less than US$1m (UK£291k revenue, or US$375k). Market cap is less than US$10m (UK£2.00m market cap, or US$2.58m). Minor Risks Latest financial reports are more than 6 months old (reported October 2022 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Annuncio • Jun 29
Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.2358 million. Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.2358 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 10,480,000
Price\Range: £0.0225
Transaction Features: Subsequent Direct Listing Reported Earnings • Dec 04
First half 2023 earnings released: UK£0.017 loss per share (vs UK£0.017 profit in 1H 2022) First half 2023 results: UK£0.017 loss per share (down from UK£0.017 profit in 1H 2022). Net loss: UK£179.5k (down 112% from profit in 1H 2022). Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Independent Non-Executive Director Howard Flight was the last independent director to join the board, commencing their role in 2006. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Annuncio • Sep 24
Marechale Capital Plc, Annual General Meeting, Oct 13, 2022 Marechale Capital Plc, Annual General Meeting, Oct 13, 2022, at 09:00 Coordinated Universal Time. Location: 46 New Broad St. London United Kingdom Reported Earnings • Aug 23
Full year 2022 earnings released: EPS: UK£0.03 (vs UK£0.004 in FY 2021) Full year 2022 results: EPS: UK£0.03 (up from UK£0.004 in FY 2021). Net income: UK£2.56m (up UK£2.32m from FY 2021). Over the last 3 years on average, earnings per share has increased by 130% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Independent Non-Executive Director Howard Flight was the last independent director to join the board, commencing their role in 2006. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Annuncio • Mar 04
Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.2075 million. Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.2075 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 6,916,667
Price\Range: £0.03
Transaction Features: Subsequent Direct Listing Reported Earnings • Dec 03
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: EPS: UK£0.017 (up from UK£0.001 loss in 1H 2021). Net income: UK£1.50m (up UK£1.57m from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 125% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Sep 09
Founder recently sold UK£83k worth of stock On the 7th of September, Patrick Booth-Clibborn sold around 3m shares on-market at roughly UK£0.028 per share. This was the largest sale by an insider in the last 3 months. This was Patrick's only on-market trade for the last 12 months. Reported Earnings • Aug 24
Full year 2021 earnings released: EPS UK£0.004 (vs UK£0.001 loss in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: UK£398.9k (down 16% from FY 2020). Net income: UK£245.9k (up UK£283.4k from FY 2020). Profit margin: 62% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Annuncio • Jan 28
Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.25 million. Marechale Capital Plc has completed a Follow-on Equity Offering in the amount of £0.25 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 20,000,000
Price\Range: £0.0125
Transaction Features: Subsequent Direct Listing Reported Earnings • Nov 27
First half 2021 earnings released: UK£0.001 loss per share The company reported a solid first half result with improved revenues and control over expenses, although earnings were flat. First half 2021 results: Revenue: UK£175.8k (up 1.6% from 1H 2020). Net loss: UK£63.4k (flat on 1H 2020). Reported Earnings • Oct 02
Full year earnings released - UK£0.00065 loss per share Over the last 12 months the company has reported total losses of UK£37.5k, with losses narrowing by 87% from the prior year. Total revenue was UK£476.5k over the last 12 months, down 6.9% from the prior year. 
